203662-91-3 Usage
Uses
Used in Pharmaceutical Synthesis:
(4-Boc-Amino-piperidin-1-yl)acetic acid ethylester is used as a building block for the development of new pharmaceutical compounds. Its ability to modify or enhance the biological activity of specific molecules contributes to the creation of more effective drugs.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (4-Boc-Amino-piperidin-1-yl)acetic acid ethylester serves as an intermediate in the synthesis of various organic molecules. Its structural properties make it a useful tool for researchers working on the design and synthesis of novel therapeutic agents.
Used in Drug Development:
(4-Boc-Amino-piperidin-1-yl)acetic acid ethylester is used as a key component in drug development, where it aids in the creation of molecules with improved pharmacological properties. Its role in enhancing the biological activity of specific molecules is crucial for the advancement of new drug candidates.
It is important to handle and store (4-Boc-Amino-piperidin-1-yl)acetic acid ethylester according to proper safety guidelines and regulations to prevent any potential hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 203662-91-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,6,6 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 203662-91:
(8*2)+(7*0)+(6*3)+(5*6)+(4*6)+(3*2)+(2*9)+(1*1)=113
113 % 10 = 3
So 203662-91-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H26N2O4/c1-5-19-12(17)10-16-8-6-11(7-9-16)15-13(18)20-14(2,3)4/h11H,5-10H2,1-4H3,(H,15,18)
203662-91-3Relevant academic research and scientific papers
TARGETING COMPOUNDS
-
Paragraph 0221, (2019/07/19)
The disclosure provides, at least in part, liver, intestine and/or kidney-targeting compounds and their use in treating liver, intestine and/or kidney disorders, such as non-alcoholic steatohepatitis, alcoholic steatohepatitis, hepatocellular carcinoma, liver cirrhosis, and hepatitis B; and/or chronic kidney disease, glomerular disease such as IGA nephropathy, lupus nephritis, or polycystic kidney disease. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
Benzopiperidine derivatives
-
, (2008/06/13)
Benzopiperidine derivatives represented by formula (I), salts thereof or hydrates thereof, processes for producing the same and drugs comprising the same: wherein the variables are as described in the specification. These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and rejection reaction accompanying organ transplantation.
